Publication | Open Access

Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-α-treated chronic myelogenous leukaemia patients

Hematological MalignancyImmunologyTumor ImmunityHematologyImmune RegulationImmune SurveillanceAutologous Target CellsHumoral ImmunityImmunomodulationLymphokine-activated EffectorsImmunologic MechanismImmune SystemMedicineCell Biology